Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,123,382
-
Share change
-
+6,911,324
-
Total reported value
-
$59,858,000
-
Put/Call ratio
-
64%
-
Price per share
-
$5.15
-
Number of holders
-
60
-
Value change
-
+$33,078,934
-
Number of buys
-
49
-
Number of sells
-
8
Institutional Holders of AVEO PHARMACEUTICALS INC - COM NEW (AVEO) as of Q2 2020
As of 30 Jun 2020,
AVEO PHARMACEUTICALS INC - COM NEW (AVEO) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,123,382 shares.
The largest 10 holders included
NEA Management Company, LLC, Cormorant Asset Management, LP, VANGUARD GROUP INC, BlackRock Inc., CITADEL ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), 683 Capital Management, LLC, Monashee Investment Management LLC, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.